ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.680
+0.030 (1.13%)
At close: May 22, 2025, 4:00 PM
2.700
+0.020 (0.75%)
After-hours: May 22, 2025, 7:41 PM EDT

ImmunityBio Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for ImmunityBio stock ranges from a low of $5.00 to a high of $30. The average analyst price target of $11.4 forecasts a 325.37% increase in the stock price over the next year.

Price Target: $11.40 (+325.37%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.00 $11.4 $8.00 $30
Change +86.57% +325.37% +198.51% +1019.4%

Analyst Ratings

The average analyst rating for ImmunityBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 122444
Buy 000001
Hold 111110
Sell 000000
Strong Sell 000000
Total 233555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Buy
Upgrades
$4.25$5
Buy Upgrades $4.25$5 +86.57% May 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +198.51% May 12, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$30
Strong Buy Maintains $30 +1,019.40% May 12, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +198.51% Apr 28, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$30
Strong Buy Maintains $30 +1,019.40% Apr 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
100.12M
from 14.75M
Increased by 579.01%
Revenue Next Year
273.94M
from 100.12M
Increased by 173.61%
EPS This Year
-0.50
from -0.62
EPS Next Year
-0.28
from -0.50
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
605.00K934.00K240.00K622.00K14.75M100.12M273.94M648.77M
Revenue Growth
-72.52%54.38%-74.30%159.17%2,270.58%579.01%173.61%136.83%
EPS
-0.59-0.89-1.04-1.15-0.62-0.50-0.280.08
EPS Growth
--------
Forward PE
-------32.84
No. Analysts
-----776
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 130.2M 353.1M 1.3B
Avg 100.1M 273.9M 648.8M
Low 83.7M 181.7M 353.1M

Revenue Growth

Revenue Growth 20252026202720282029
High
783.0%
252.7%
359.6%
Avg
579.0%
173.6%
136.8%
Low
467.5%
81.4%
28.9%

EPS Forecast

EPS 20252026202720282029
High -0.44 -0.23 0.54
Avg -0.50 -0.28 0.08
Low -0.57 -0.33 -0.11

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.